Pfizer Inc. PFE today announced an update of its clinical trial
data access policy that will simplify and broaden access to information
gathered in Pfizer-sponsored clinical trials. The updated policy builds
upon and expands the company's established methods of clinical trial
information sharing, including Pfizer's long track record of submitting
for publication results from all interventional clinical trials in
patients and its pioneering efforts to provide clinical trial results
and data to study participants.
Pfizer's updated policy meets or exceeds the “Principles
for Responsible Data Sharing” issued by the Pharmaceutical Research
and Manufacturers of America (PhRMA) and the European Federation of
Pharmaceutical Industries and Associations (EFPIA) in July 2013.
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in